» Authors » Anders Opdahl

Anders Opdahl

Explore the profile of Anders Opdahl including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 43
Citations 1618
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Van Mieghem N, Windecker S, Manoharan G, Lancellotti P, Tamburino C, Kornowski R, et al.
Catheter Cardiovasc Interv . 2024 Dec; 105(3):577-587. PMID: 39686582
Background: The self-expanding, supra-annular Evolut valve is an established platform for Transcatheter Aortic Valve Implantation (TAVI). Evolut PRO introduced an outer sealing wrap to mitigate paravalvular leakage. We evaluated the...
2.
Kindberg K, Broch K, Andersen G, Anstensrud A, Akra S, Woxholt S, et al.
JACC Adv . 2024 Sep; 3(9):101193. PMID: 39247678
Background: Interleukin-6-receptor inhibition with tocilizumab improves myocardial salvage in patients with ST-segment elevation myocardial infarction (STEMI). Reduced levels of neutrophil extracellular traps (NETs), which consist of nuclear material studded with...
3.
Dodgson C, Beitnes J, Klove S, Herstad J, Opdahl A, Undseth R, et al.
Am Heart J . 2023 Aug; 265:225-232. PMID: 37634655
Background: The optimal antithrombotic therapy after transcatheter aortic valve implantation (TAVI) is unknown. Bioprosthetic valve dysfunction (BVD) is associated with adverse outcomes and may be prevented by anticoagulation therapy. A...
4.
Huse C, Anstensrud A, Michelsen A, Ueland T, Broch K, Woxholt S, et al.
EBioMedicine . 2022 May; 80:104013. PMID: 35504178
Background: We recently showed that interleukin (IL)-6 inhibition by tocilizumab improves myocardial salvage in ST-elevation myocardial infarction (STEMI). However, the mechanisms for this effect are not clear. Methods: In this...
5.
Broch K, Anstensrud A, Woxholt S, Sharma K, Tollefsen I, Bendz B, et al.
J Am Coll Cardiol . 2021 Apr; 77(15):1845-1855. PMID: 33858620
Background: Prompt myocardial revascularization with percutaneous coronary intervention (PCI) reduces infarct size and improves outcomes in patients with ST-segment elevation myocardial infarction (STEMI). However, as much as 50% of the...
6.
Due-Tonnessen N, Egeland C, Meyerdierks O, Opdahl A
Eur J Cardiovasc Nurs . 2021 Feb; 20(6):580-587. PMID: 33615328
Aims: Vascular access site complications following transradial coronary procedures are less common and severe compared to femoral approach. Radial artery occlusion is considered the main adverse effect. As radial access...
7.
Anstensrud A, Woxholt S, Sharma K, Broch K, Bendz B, Aakhus S, et al.
Open Heart . 2019 Nov; 6(2):e001108. PMID: 31673391
Introduction: Interleukin-6 (IL-6) may be involved in ischaemia-reperfusion injury and myocardial remodelling after myocardial infarction (MI). We have recently shown that IL-6 inhibition by tocilizumab attenuates systemic inflammation and troponin...
8.
Al-Ani A, Hoffmann P, von Lueder T, Opdahl A
Catheter Cardiovasc Interv . 2019 Aug; 95(6):1171-1175. PMID: 31379116
Objectives: To evaluate the clinical utility and feasibility of a hybrid technique for obtaining vascular hemostasis by combining a suture- and a collagen-mediated system after transfemoral transcatheter aortic valve implantation...
9.
Redheuil A, Kachenoura N, Bollache E, Yu W, Opdahl A, Decesare A, et al.
Am J Physiol Heart Circ Physiol . 2019 Apr; 317(2):H300-H307. PMID: 30978118
The importance of aorta-ventricular coupling in cardiovascular disease is recognized but underestimated. The contribution of the age-related decline in ascending aortic function compared with characteristic impedance and total peripheral resistance...
10.
Hoffmann P, Al-Ani A, von Lueder T, Skoe O, Tran T, Opdahl A
EJVES Short Rep . 2019 Apr; 42:34-36. PMID: 30931405
Introduction: Access site vascular complications in transfemoral transcatheter aortic valve implantation (TF-TAVI) are still a major concern. Recently, a novel collagen plug based closure device (Manta) was introduced. The results...